Pharmaceuticals RSS Feeds

Directory4 pharmaceuticals feeds · 18 articlesEnglish only →

Latest

Pharmaceuticals articles

Replimune to resubmit melanoma drug for FDA approval after agency leadership changes

Replimune plans to resubmit its melanoma drug for FDA approval following a leadership shakeup at the agency. The drug was twice rejected under former FDA leadership, including Commissioner Marty Makary who recently stepped down. Replimune had accused the FDA of wrongfully blockin

Newshealthbusinesspharmaceuticals

Eli Lilly's experimental gene-editing therapy VERVE-102 shows promise as one-time treatment for high cholesterol

Newssciencehealthpharmaceuticals

Shared by @spennington.bsky.social on Bluesky ↗

abcnews.com3d ago

GLP-1 weight loss drugs reduce food spending, creating a $6.5 billion challenge for major grocery retailers

Insighthealthbusinessretail

Shared by @bradenton.com on Bluesky ↗

bit.ly4d ago

Ebola Outbreak Spreads as Eli Lilly Invests $4 Billion in Vaccine Deals

Newshealthbusinesspublic health

Shared by @forbes.com on Bluesky ↗

forbes.com4d ago

�

Novo Nordisk loses global market lead to Eli Lilly outside the US

Newshealthbusinesscorporate strategy

Shared by @finans.dk on Bluesky ↗

finans.dk5d ago

Decades of sleep physiology research at University of Toronto leads to new sleep apnea drug showing promise in Phase 3 trial

Newssciencehealthmedical research

temertymedicine.utoronto.ca9d ago

Study: Stopping GLP-1 Drugs Increases Heart Attack and Stroke Risk

Newssciencehealthmedical research

nautil.us2mo ago

Modified Fentanyl Molecule Reduces Respiratory Risk While Maintaining Pain Relief

Researchers have developed a modified version of fentanyl that reduces the dangerous respiratory depression side effect while maintaining full pain-blocking capabilities. The structural redesign addresses the leading cause of opioid overdose deaths, potentially creating safer pai

Newssciencehealthmedical researchscripps.edu·Hacker News: Front Page·3mo ago·4 min read

Synthetic Psilocybin Shows Strong Results in Treatment-Resistant Depression Trials

Compass Pathways, a British biotech company, announced strong results from two late-stage trials showing that a synthetic form of psilocybin (the active compound in magic mushrooms) can rapidly relieve symptoms in patients with treatment-resistant depression. The FDA is now revie

Newssciencemental healthhealth

economist.com·Hacker News: Front Page·3mo ago·1 min read

FDA Announces Plans to Restrict Non-Approved GLP-1 Drugs in Compounded Medications

The FDA is announcing its intent to take action against non-FDA-approved GLP-1 drugs, specifically targeting GLP-1 active pharmaceutical ingredients used in compounded drugs that are being mass-marketed by companies. The agency plans to restrict these ingredients in compounded me

Newshealthnewsregulation

fda.gov·Hacker News: Front Page·3mo ago·2 min read

Study: Ozempic and Wegovy Reduce Household Food Spending and Change Purchasing Patterns

Newssciencehealthconsumer behavior

news.cornell.edu4mo ago

Novo Nordisk launches first GLP-1 weight loss pill Wegovy in US at lower price than injections

Newshealthbusinesspharmaceuticals

theguardian.com4mo ago

Study: Most Patients Regain Weight and Lose Health Benefits After Stopping GLP-1 Drugs

Newssciencehealthmedical research

arstechnica.com6mo ago

Kenvue Stock Drops 10% on Report Linking Tylenol Use During Pregnancy to Autism

Kenvue's stock dropped over 10% following a Wall Street Journal report that HHS Secretary Robert F. Kennedy Jr. will likely release a report this month linking Tylenol use during pregnancy to autism. The report, based on what HHS calls 'gold-standard science,' will also suggest f

Newshealthbusinesspharmaceuticals

cnbc.com·Hacker News: Front Page·8mo ago·3 min read

Tylenol-maker's stock declines amid RFK Jr's reported plans to suggest autism link

Newshealthbusinesspublic health controversy

bbc.com8mo ago

PharmiWeb4

Replimune to resubmit melanoma drug for FDA approval after agency leadership changes

Eli Lilly's experimental gene-editing therapy VERVE-102 shows promise as one-time treatment for high cholesterol

GLP-1 weight loss drugs reduce food spending, creating a $6.5 billion challenge for major grocery retailers

Ebola Outbreak Spreads as Eli Lilly Invests $4 Billion in Vaccine Deals

Novo Nordisk loses global market lead to Eli Lilly outside the US

Decades of sleep physiology research at University of Toronto leads to new sleep apnea drug showing promise in Phase 3 trial

Study: Stopping GLP-1 Drugs Increases Heart Attack and Stroke Risk

Modified Fentanyl Molecule Reduces Respiratory Risk While Maintaining Pain Relief

Synthetic Psilocybin Shows Strong Results in Treatment-Resistant Depression Trials

FDA Announces Plans to Restrict Non-Approved GLP-1 Drugs in Compounded Medications

Study: Ozempic and Wegovy Reduce Household Food Spending and Change Purchasing Patterns

Novo Nordisk launches first GLP-1 weight loss pill Wegovy in US at lower price than injections

Study: Most Patients Regain Weight and Lose Health Benefits After Stopping GLP-1 Drugs

Study Finds Ozempic Does Not Slow Alzheimer's Disease Progression

Texas Attorney General Sues Tylenol Makers Over Autism Risk Claims

Interview with Sandoz CEO Richard Saynor on Generic Pharmaceuticals Industry

Kenvue Stock Drops 10% on Report Linking Tylenol Use During Pregnancy to Autism

Tylenol-maker's stock declines amid RFK Jr's reported plans to suggest autism link